Prospects for the early diagnosis of invasive aspergillosis in the immunocompromised patient

Reviews and Research in Medical Microbiology

Volumn 7, Issue 2, 1996, Pages 105-113

  Verweij, Paul E ^a   Donnelly, J Peter ^a   De Pauw, Ben E ^a   Meis, Jacques F G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

(pre emptive) therapy; Antigen detection; Diagnosis; Invasive aspergillosis; PCR

Indexed keywords

FUNGUS ANTIGEN; GALACTOMANNAN; MONOCLONAL ANTIBODY;

ASPERGILLOSIS; ASPERGILLUS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE DEFICIENCY; LATEX AGGLUTINATION TEST; LUNG LAVAGE; MORBIDITY; MORTALITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW;

EID: 0029986882     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-199604000-00005     Document Type: Review

References (55)

1. Sheretz RJ, Belani A, Kramer BS et al. Impact of air filtration on nosocomial Aspergillus infection. Am J Med 1987; 83: 709-718.
2. Working party of the British Society for Antimicrobial Chemotherapy. Chemoprophyaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendations. J Antimicrob Chemother 1993; 32: 5-21.
3. Aisner J, Murillo J, Schimpff SC, Steere AC. Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. An Intern Med 1979; 90: 4-9.
4. Bodey GP, Anaissie E, Gutterman J, Vadhan RS. Role of granulocyte-macrophage stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infection. Eur J Clin Microbiol Infect Dis 1994; 13 (suppl 2): S18-S22.
5. Lee JW, Amantea MA, Francis PA et al. Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (Ambisome) in rabbits. Antimicrob Agents Chemother 1994; 38: 713-718.
6. Yu VL, Muder RR, Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive aspergillosis. Results from a three-year prospective study. Am J Med 1986; 81: 249-254.
7. Nalesnik MA, Myerowitz RL, Jenkins R, Lenkey J, Herbert D. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 1980; 11: 370-376.
8. Levy H, Horak DA, Tegtmeier BR, Yokota SB, Forman SJ. The value of bronchoalveolar lavage and bronchial washings in the diagnosis of invasive pulmonary aspergillosis. Resp Med 1992; 86: 243-248.
9. Saito H, Anaissie EJ, Morice RC, Dekmezian R, Bodey GP. Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia. Chest 1988; 94: 745-749.
10. Steven MA, Talbot GH, Gerson SL, Miller WT, Cassileth PA. Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukaemia. Am J Med 1984; 76: 1027-1034.
11. McWhinney PHM, Kibbler CC, Hamon MD et al. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis 1993; 17: 397-404.
12. Aisner J, Schimpff SC, Wiernik PH. Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Ann Intern Med 1977; 86: 539-543.
13. Reddy LV, Kumar A, Kurup VP. Specific amplification of Aspergillus fumigatus DNA by polymerase chain reaction. Mol Cell Probes 1993; 7: 121-126.
14. Spreadbury C, Holden D, Aufauvre-Brown A, Bainbridge B, Cohen J. Detection of Aspergillus fumigatus by polymerase chain reaction. J Clin Microbiol 1993; 31: 615-621.
15. Bretagne S, Costa JM, Marmorat-Khuong A et al. Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR. J Clin Microbiol 1995; 33: 1164-1168.
16. Melchers WJG, Verweij PE, Van den Hurk P et al. General primer-mediated PCR for detection of Aspergillus species. J Clin Microbiol 1994; 32: 1710-1717.
17. Tang CM, Holden DW, Aufauvre-Brown A, Cohen J. The detection of Aspergillusd spp. by the polymerase chain reaction and its evaluation in bronchoalveolar lavage fluid. Am Rev Resp Dis 1993; 148: 1313-1317.
18. Verweij PE, Meis JFGM, Van den Hurk P, Zoll J, Samson RA, Melchers WJG. Phylogenetic relationships of five species of Aspergillus and related taxa as deduced by comparison of sequences of small subunit ribosomal RNA. J Med Vet Mycol 1995; 33: 185-190.
19. Verweij PE, Meis JFGM, Van den Hurk P, De Pauw BE, Hoogkamp-Korstanje JAA, Melchers WJG. Polymerase chain reaction as a diagnostic tool for invasive aspergillosis: evaluation in bronchoalveolar lavage fluid from low risk patients. Serodiagn Immunother Infect Dis 1994; 6: 203-208.
20. Kwok S, Higichi R. Avoiding false positives with PCR. Nature 1989; 339: 237-238.
21. Nelson LA, Callerame ML, Schwartz RH. Aspergillosis and atopy in cystic fibrosis. Am Rev Respir Dis 1979; 120: 863-873.
22. Pursell KI, Telzak EE, Armstrong D. Aspergillus species colonization and invasive disease in patients with AIDS. Clin Infect Dis 1992; 14: 141-148.
23. Young R, Bennett JE. Invasive aspergillosis: absence of detectable antibody response. Am Rev Respir Dis 1971; 104: 710-716.
24. Andrews CP, Weiner MH. Immunodiagnosis of invasive aspergillosis in rabbits. Fungal antigen detected by radioimmunoassay in bronchoalveolar lavage fluid. Am Rev Respir Dis 1981; 124: 60-64.
25. Haynes KA, Latgé JP, Rogers TR. Detection of Aspergillus antigens associated with invasive infection. J Clin Microbiol 1990; 28: 2040-2044.
26. Rogers TR, Haynes KA, Barnes RA. Value of antigen detection in predicting invasive pulmonary aspergillosis. Lancet 1990; 336: 1210-1213.
27. Sabetta JR, Miniter P, Andriole VT. The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen. J Infect Dis 1985; 152: 946-953.
28. Talbot GH, Weiner MH, Gerson SL, Provencher M, Hurwitz S. Serodiagnosis of invasive aspergillosis in patients with hematologic malignancy: validation of the Aspergillus fumigatus antigen radioimmunoassay. J Infect Dis 1987; 155: 12-27.
29. Dupont B, Huber M, Kim SJ, Bennett JE. Galactomannan antigenemia and antigenuria in aspergillosis: studies in patients and experimentally infected rabbits. J Infect Dis 1987; 155: 1-11.
30. Reiss E, Lehmann PF. Galactomannan antigenemia in invasive aspergillosis. Infect Immun 1979; 25: 357-365.
31. Piérard GE, Arrese Estrada J, Piérard-Franchimont C, Thiry A, Stynen D. Immunohistochemical expression of galactomannan in the cytoplasm of phagocytic cells during invasive aspergillosis. Am J Clin Pathol 1991; 96: 373-376.
32. Stynen D, Sarfati J, Goris A et al. Rat monoclonal antibodies against Aspergillus galactomannan. Infect Immun 1992; 60: 2237-2245.
33. Ansorg R, Heintschel von Heinegg E, Rath PM. Aspergillus antigenuira compared to antigenemia in bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis 1994; 13: 582-589.
34. Haynes K, Rogers TR. Retrospective evaluation of a latex agglutination for diagnosis of invasive aspergillosis in immunocompromised patients. Eur J Clin Microbiol Infect Dis 1994; 13: 670-674.
35. Hopwood V, Johnson EM, Cornish JM, Foot ABM, Evans EGV, Warnock DW. Use of the Pastorex Aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis. J Clin Pathol 1995; 48: 210-213.
36. Manso E, Montillo M, De Sio G, D'Amico S, Discepoli G, Leoni P. Value of antigen and antibody detection in the serological diagnosis of invasive aspergillosis in patients with hematological malignancies. Eur J Clin Microbiol Infect Dis 1994; 13:: 756-760.
37. Verweij PE, Rijs AJMM, De Pauw BE, Horrevorts AM, Hoogkamp-Korstanje JAA, Meis JFGM. Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis. J Clin Pathol 1995; 48: 474-476.
38. Francis P, Lee JW, Hoffman A et al. Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection. J Infect Dis 1994; 169: 356-368.
39. Lortholary O, Meyohas MC, Dupont B et al. Invasive aspergillosis in patients with acquired immunodeficiency syndrome. Am J Med 1993; 95: 177-187.
40. Kappe R, Schulze-Berge A. New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test. J Clin Microbiol 1993; 31: 2489-2490.
41. Stynen D, Goris A, Sarfati J, Latgé JP. A new sensitive sandwich ELISA to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995; 33: 497-500.
42. Verweij PE, Stynen D, Rijs AJMM, De Pauw BE, Hoogkamp-Korstanje JAA, Meis JFGM. Sandwich enzyme-linked immunoassay compared with Pastorex test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol 1995; 33: 1912-1914.
43. Verweij PE, Latgé JP, Rijs AJMM et al. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J Clin Microbiol 1995; 33: 3150-3153.
44. Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign and the role of CT in early diagnosis. Radiology 1985; 157: 611-614.
45. Walsh TJ, Garrett K, Feuerstein E et al. Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy. Antimicrob Agents Chemother 1995; 39: 1065-1069.
46. Denning DW. Treatment of invasive aspergillosis. J. Infect 1994; 28 (suppl 1): 25-33.
47. Walsh TJ, Lee J, Lecciones J et al. Empiric therapy with amphotericin B in febrile granulocytopenic patients. Rev Infect Dis 1991; 13: 496-503.
48. Navarro E, Lecciones J, Witebsky F et al. Invasive aspergillosis developing during empirical antifungal therapy. 90th Annual Meeting of the American Society for Microbiology, Washington DC 1990; abstract F71: 420.
49. Fraser I, Denning DW. Empiric amphotericin B therapy. The need for a reappraisal. Blood Rev 1993; 7: 208-214.
50. Iwen PC, Reed EC, Armitage JO et al. Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Infect Control Hosp Epidemiol 1993; 14: 131-139.
51. Torre-Cisneros J, Lopez OL, Kusne S et al. CNS aspergillosis in organ transplantation: a clinicopathological study. J Neurol Neurosurg Psychiatry 1993; 56: 188-193.
52. Collins LA, Samore MH, Roberts MS et al. Risk factors for invasive fungal infections complicating orthotopic liver transplanation. J Infect Dis 1994; 170: 644-652.
53. Kramer MR, Marshal SE, Starnes VA, Gamberg P, Amitai Z, Theodore J. Infectious complications in heart-lung transplanation. Arch Intern Med 1993; 153: 2010-2016.
54. Hofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS. Infectious complications in heart transplant recipients receiving cyclosporin and corticosteroids. Ann Intern Med 1987; 106: 209-216.
55. Schwartz RS, Mackintosh FR, Schrier SL, Greenberg PL. Multivariate analysis of factors associated with invasive fungal infection during remission induction therapy for acute myelogenous leukemia. Cancer 1984; 53: 411-419.